Crystalline Management’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$12K Hold
80,000
0.01% 59
2024
Q2
$5.68K Hold
80,000
0.01% 68
2024
Q1
$2.8K Hold
80,000
﹤0.01% 72
2023
Q4
$2.26K Hold
80,000
﹤0.01% 73
2023
Q3
$4.79K Hold
80,000
﹤0.01% 92
2023
Q2
$4.76K Hold
80,000
﹤0.01% 98
2023
Q1
$2.74K Buy
+80,000
New +$5.18K ﹤0.01% 94

Other funds holding SBCWW

Crystalline Management's SBCWW Position: Q3 2024 in Review

Crystalline Management held its SBC Medical Group Warrants (SBCWW) position steady in Q3 2024 at 80,000 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #59.

Crystalline Management first reported a position in SBCWW in Q1 2023 and has held it in 7 quarters since. 27 funds tracked by Wall St. Rank hold SBCWW as of Q3 2024.

  • Crystalline Management held 80,000 shares of SBC Medical Group Warrants worth $12K as of Q3 2024.
  • Crystalline Management left its SBC Medical Group Warrants share count unchanged in Q3 2024.
  • SBC Medical Group Warrants made up 0.01% of Crystalline Management's portfolio in Q3 2024, its #59 holding.
  • Crystalline Management first reported a position in SBC Medical Group Warrants in Q1 2023 and has held it in 7 quarters since.
  • 27 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q3 2024.

Based on Crystalline Management's 13F filing for Q3 2024, filed 8 Nov 2024.